| 000 | 01609 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513150634.0 | ||
| 264 | 0 | _c19980821 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1046/j.1365-2249.1998.00604.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNicoletti, F | |
| 245 | 0 | 0 |
_aBlood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cJul 1998 |
||
| 300 |
_a96-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xblood |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xblood |
| 700 | 1 | _aDi Marco, R | |
| 700 | 1 | _aPatti, F | |
| 700 | 1 | _aReggio, E | |
| 700 | 1 | _aNicoletti, A | |
| 700 | 1 | _aZaccone, P | |
| 700 | 1 | _aStivala, F | |
| 700 | 1 | _aMeroni, P L | |
| 700 | 1 | _aReggio, A | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 113 _gno. 1 _gp. 96-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2249.1998.00604.x _zAvailable from publisher's website |
| 999 |
_c9663623 _d9663623 |
||